Status:
UNKNOWN
Evaluation of Vitrectomy With ILM Peeling in Myopic Macular Hole With Only Posterior Retinal Detachment
Lead Sponsor:
Al-Azhar University
Conditions:
Retinal Detachment
Eligibility:
All Genders
15-60 years
Phase:
NA
Brief Summary
Retinal detachment (RD) resulting from the macular hole (MH), also known as MH-induced RD (MHRD), most commonly occurs in eyes with high myopia and results in irreversible visual disorders. Although I...
Eligibility Criteria
Inclusion
- patients with high myopia (a spherical equivalent refractive error of at least -6.0 diopters (D) and an axial length of at least 26.5 mm).
- Macular hole and only posterior retinal detachment
Exclusion
- Other causes of RD
- Patients with a history of trauma, choroidal neovascularization, coexistence with a peripheral retinal break or proliferative vitreoretinopathy
- History of any vitreoretinal surgery prior to MHRD and less than 36 months of follow-up after the surgery
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2024
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT06194760
Start Date
January 1 2022
End Date
January 15 2024
Last Update
January 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ehab tharwat
Damietta, New Damietta, Egypt, 34517